SCHEMBL8092280

SCHEMBL8092280

C(CCNCC1CCCCC1)CCC1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.62
CYP1A2 P05177 1/20 0.45
GNAI3 P08754 1/20 0.44
GNAO1 P09471 1/20 0.44
GNAI1 P63096 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
SAT1 P21673 1/20 0.44
KDM5A P29375 3/20 0.42
PHF8 Q9UPP1 3/20 0.42
KDM2A Q9Y2K7 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9378642 0.98 SIGMAR1 (0.60) SIGMAR1CYP1A2GNAI3GNAO1GNAI1
SCHEMBL893878 0.84 SAT1 (0.58) SIGMAR1GNAI3GNAO1GNAI1HDAC3
SCHEMBL11067343 0.83 EPHX1 (0.47) SIGMAR1GNAI3GNAO1GNAI1HDAC3
SCHEMBL24500037 0.82 ADH1B (0.48) SIGMAR1CYP1A2HDAC3HDAC4HDAC1
SCHEMBL14606660 0.82 ADH1B (0.48) SIGMAR1CYP1A2HDAC3HDAC4HDAC1
SCHEMBL21799482 0.82 SIGMAR1 (0.55) SIGMAR1CYP1A2GNAI3GNAO1GNAI1
SCHEMBL8603624 0.82 GNAI3 (0.66) SIGMAR1CYP1A2GNAI3GNAO1GNAI1
SCHEMBL21799651 0.82 SIGMAR1 (0.55) SIGMAR1CYP1A2GNAI3GNAO1GNAI1
SCHEMBL21799707 0.82 SIGMAR1 (0.55) SIGMAR1CYP1A2GNAI3GNAO1GNAI1
SCHEMBL21799693 0.82 SIGMAR1 (0.55) SIGMAR1CYP1A2GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed